Therapy ambitions. Each and every GLP-one agonist has distinct authorised employs and potential Advantages to assist you satisfy your therapy aims. In October 2024, Novo Nordisk revealed a review on scientific journal Nature about a novel glucose-delicate insulin NNC2215 that can reduce the p